At AHA’s Urging, DEA Takes Steps to Address IV Opioid Shortages

Apr 06, 2018 - 03:23 PM
iv-opioid-shortage

At the request of AHA and others, the Drug Enforcement Administration has taken steps that will address the IV opioid shortages. DEA recently granted some additional quota for raw materials to West-Ward Pharmaceuticals and Fresenius Kabi USA so that they can produce certain injectable opioid medications that are experiencing severe shortages. The Food and Drug Administration has updated its drug shortage database to reflect the upcoming availability of these products. Both drug companies will continue work with DEA on additional quota requests to try to accommodate hospitals’ supply needs for these products in the upcoming months. On Feb. 27, the AHA and several other national pharmacy, medical, and safety organizations sent DEA a letter urging the agency to temporarily adjust the aggregate production quotas for injectable opioid medications in short supply to allow other manufacturers to supply product until the shortages resolve. For more information about how to access these products, the FDA’s database includes customer service contact information for these and other drug companies. The AHA this week shared with hospitals and health systems a new resource developed by the American Society of Health-System Pharmacists and the University of Utah Drug Information Service with suggestions for managing the injectable opioid shortages.

Related News Articles

Chairperson's File
Chairman’s File: Podcast — driving value by addressing the social determinants of health
Hospitals and health systems recognize that addressing social determinants of health is central to driving value and advancing overall well-being.
Headline
SAMHSA offering webinars on recovery supports for opioid use disorder
The Substance Abuse and Mental Health Services Administration will launch a three-part virtual learning series on recovery supports for people considering or…
Headline
AHA’s chief medical officer named Aspen Institute Health Innovators fellow
The Aspen Institute recently chose AHA Senior Vice President and Chief Medical Officer Jay Bhatt, D.O., to participate in its Health Innovators Fellowship.
Headline
CDC: Drug overdose deaths fell 5.1% in 2018
Drug overdose deaths declined 5.1% in 2018 to about 68,000, according to preliminary data from the Centers for Disease Control and Prevention.
Headline
Ways and Means Committee launches health care task force
The House Ways and Means Committee today launched a health task force to better address the needs of residents in rural and underserved communities.
Headline
Medicare proposes covering acupuncture for some back pain patients
Under a new Centers for Medicare…